Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estelle Guerin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
International Journal of Hematology|January 7, 2012
mPGES-1 in leukemic cells of AML patientsPauline Rouaud, Estelle Guerin, Dominique Bordessoule, et al.
Leukemia & Lymphoma|January 29, 2011
Phospholipase A2 receptors in human leukemic blastsRada Amin, Rémi Fiancette, Dominique Bordessoule, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2012
T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cellsDavid Rizzo, Gaëlle Bouvier, Ibtissam Youlyouz-Marfak, et al.
Journal of Leukocyte Biology|February 17, 2024
Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in emergency departmentsThomas Lafon, Nicolas Chapuis, Estelle Guerin, et al.
Blood|December 28, 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaElise Fournier, Nicolas Duployez, Benoît Ducourneau, et al.
Blood|March 2, 2016
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemiaGuillaume Olombel, Estelle Guerin, Julien Guy, et al.
Leukemia|October 7, 2021
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AMLMatthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, et al.
Chest|April 30, 2018
Multicentric Standardized Flow Cytometry Routine Assessment of Patients With Sepsis to Predict Clinical WorseningThomas Daix, Estelle Guerin, Elsa Tavernier, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Oncology|October 19, 2010
Lipid mediators and human leukemic blastsRémi Fiancette, Christelle Vincent-Fabert, Estelle Guerin, et al.
International Journal of Hematology|January 7, 2012
mPGES-1 in leukemic cells of AML patientsPauline Rouaud, Estelle Guerin, Dominique Bordessoule, et al.
Leukemia & Lymphoma|January 29, 2011
Phospholipase A2 receptors in human leukemic blastsRada Amin, Rémi Fiancette, Dominique Bordessoule, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2012
T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cellsDavid Rizzo, Gaëlle Bouvier, Ibtissam Youlyouz-Marfak, et al.
Journal of Leukocyte Biology|February 17, 2024
Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in emergency departmentsThomas Lafon, Nicolas Chapuis, Estelle Guerin, et al.
Blood|December 28, 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaElise Fournier, Nicolas Duployez, Benoît Ducourneau, et al.
Blood|March 2, 2016
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemiaGuillaume Olombel, Estelle Guerin, Julien Guy, et al.
Leukemia|October 7, 2021
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AMLMatthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, et al.
Chest|April 30, 2018
Multicentric Standardized Flow Cytometry Routine Assessment of Patients With Sepsis to Predict Clinical WorseningThomas Daix, Estelle Guerin, Elsa Tavernier, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Pageof 1